Evaluating Once-Yearly Salanersen Across the Spinal Muscular Atrophy Spectrum: A Phase 3 Clinical Program

Welcome to NeurologyLive's Clinical Trial in Focus. Every month, an ongoing clinical trial in the landscape of neurology is featured, highlighting the design of the study, the targeted patient population, the enrollment criteria, the primary and secondary end points, and its potential implications for clinical care.